We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,183.50 +16.00 (+0.31%) Dow Futures
38,344.00 +106.00 (+0.28%) Nasdaq Futures
18,236.75 +57.50 (+0.32%) Russell 2000 Futures
2,032.80 +13.00 (+0.64%) Crude Oil
85.67 +0.01 (+0.01%) Gold
2,378.50 +4.40 (+0.19%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 145.00 |
| Open | 143.59 |
| Bid | 139.76 x 1400 |
| Ask | 151.15 x 900 |
| Day's Range | 140.26 - 144.66 |
| 52 Week Range | 96.80 - 151.58 |
| Volume | |
| Avg. Volume | 1,572,896 |
| Market Cap | 41.242B |
| Beta (5Y Monthly) | 1.12 |
| PE Ratio (TTM) | 33.67 |
| EPS (TTM) | 4.18 |
| Earnings Date | May 21, 2024 - May 27, 2024 |
| Forward Dividend & Yield | 0.94 (0.67%) |
| Ex-Dividend Date | Apr 01, 2024 |
| 1y Target Est | 148.89 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for A
Related Research
- Agilent Technologies, Inc.A: Raising target price to $155.00AGILENT TECHNOLOGIES INC has an Investment Rating of HOLD; a target price of $155.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.RatingFair ValueEconomic Moat5 days agoArgus Research
ZacksWaters (WAT) Boosts Waters Operating Segment With HPLC System
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
MedTech DiveIllumina CFO steps down amid executive shakeup
Ankur Dhingra, who worked with Illumina’s CEO at Agilent Technologies, is joining the genome sequencing company to replace Joydeep Goswami.
ZacksAgilent (A) is Set for Analytica 2024 With Advanced Products
Agilent (A) plans to showcase its new products for analytical laboratories at Analytica 2024, boosting its overall product portfolio.
Simply Wall St.Is Now An Opportune Moment To Examine Agilent Technologies, Inc. (NYSE:A)?
Let's talk about the popular Agilent Technologies, Inc. ( NYSE:A ). The company's shares saw a decent share price...
ZacksAgilent (A) to Bolster DCG Segment With Upcoming Solutions
Agilent (A) plans to introduce new solutions for cancer research and diagnosis, boosting its DCG segment.
Business WireAgilent Brings Great Science to Life at Analytica 2024
SANTA CLARA, Calif., April 04, 2024--Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.
Business WireAgilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
SANTA CLARA, Calif., April 03, 2024--Agilent Technologies Inc. (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the American Association for Cancer Research Annual Meeting (AACR). At the meeting, which will take place from April 5 to 10, 2024, in San Diego, CA, Agilent will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions.
ZacksAgilent (A) Boosts LSAG Segment With Advanced Dilution System
Agilent (A) unveils ADS 2 to enhance workflow efficiency within the laboratory, boosting the LSAG segment.
Business WireAgilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
SANTA CLARA, Calif. & SAN DIEGO, April 02, 2024--Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC San Diego), one of the top-ranked public research universities in the world, today announced an innovative scientific collaboration to establish the Agilent Center of Excellence (CoE) in Cellular Intelligence.
Business WireAgilent Launches New Advanced Dilution System to Increase Lab Efficiency
SANTA CLARA, Calif., April 01, 2024--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| KEYS Keysight Technologies, Inc. | |||
| HPQ HP Inc. | |||
| ADI Analog Devices, Inc. | |||
| JNPR Juniper Networks, Inc. | |||
| TMO Thermo Fisher Scientific Inc. |
Similar to A
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| WAT Waters Corporation | |||
| MTD Mettler-Toledo International Inc. | |||
| TMO Thermo Fisher Scientific Inc. | |||
| DHR Danaher Corporation | |||
| RVTY Revvity, Inc. |
Analyst Price Targets (17)
Upgrades & Downgrades
| Maintains | Barclays: Underweight to Underweight | 4/10/2024 | |
| Upgrade | Stifel: Hold to Buy | 4/5/2024 | |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 | |
| Maintains | Oppenheimer: Outperform to Outperform | 3/26/2024 | |
| Maintains | Citigroup: Neutral to Neutral | 2/28/2024 | |
| Maintains | UBS: Neutral to Neutral | 2/28/2024 |
Company Profile
5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
https://www.agilent.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 17,700
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
